Aethlon Interest Income vs Cost Of Revenue Analysis

AEMD Stock  USD 0.58  0.15  34.88%   
Aethlon Medical financial indicator trend analysis is way more than just evaluating Aethlon Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aethlon Medical is a good investment. Please check the relationship between Aethlon Medical Interest Income and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.

Interest Income vs Cost Of Revenue

JavaScript chart by amCharts 3.21.1520142016201820202022202450K100K150K200K250K300K350K400K450K500K550K600K650K 500M1B1.5B2B2.5B3B3.5B4B4.5B
JavaScript chart by amCharts 3.21.15Interest Incometotal: 3.8MCost Of Revenuetotal: 24.4B

Interest Income vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aethlon Medical Interest Income account and Cost Of Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.
Interest IncomeCost Of RevenueDiversified AwayInterest IncomeCost Of RevenueDiversified Away100%
The correlation between Aethlon Medical's Interest Income and Cost Of Revenue is -0.26. Overlapping area represents the amount of variation of Interest Income that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Aethlon Medical, assuming nothing else is changed. The correlation between historical values of Aethlon Medical's Interest Income and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Income of Aethlon Medical are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Interest Income i.e., Aethlon Medical's Interest Income and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

-0.26
Relationship DirectionNegative 
Relationship StrengthInsignificant

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.

Cost Of Revenue

Cost of Revenue is found on Aethlon Medical income statement and represents the costs associated with goods and services Aethlon Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Most indicators from Aethlon Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aethlon Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.At present, Aethlon Medical's Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 0.01, whereas Sales General And Administrative To Revenue is forecasted to decline to 6.30.

Aethlon Medical fundamental ratios Correlations

-0.27-0.340.86-0.97-0.740.970.650.380.97-0.40.680.79-0.30.97-0.380.68-0.070.56-0.77-0.36-0.4-0.06-0.32-0.840.19
-0.270.94-0.70.390.23-0.27-0.17-0.16-0.270.93-0.22-0.330.95-0.260.92-0.190.33-0.180.450.680.85-0.030.190.29-0.1
-0.340.94-0.770.490.27-0.35-0.16-0.14-0.350.98-0.21-0.371.0-0.340.97-0.190.48-0.170.530.860.960.070.360.32-0.14
0.86-0.7-0.77-0.92-0.650.850.520.330.85-0.80.580.74-0.740.84-0.780.56-0.30.47-0.81-0.71-0.79-0.07-0.4-0.760.21
-0.970.390.49-0.920.67-0.98-0.5-0.24-0.980.52-0.55-0.730.46-0.970.5-0.540.25-0.410.740.550.550.060.340.8-0.26
-0.740.230.27-0.650.67-0.64-0.74-0.67-0.640.34-0.78-0.990.22-0.640.36-0.73-0.04-0.720.650.320.410.620.430.8-0.1
0.97-0.27-0.350.85-0.98-0.640.470.171.0-0.380.510.69-0.331.0-0.350.52-0.180.37-0.66-0.39-0.4-0.01-0.24-0.770.24
0.65-0.17-0.160.52-0.5-0.740.470.880.47-0.260.960.76-0.10.47-0.271.00.40.99-0.82-0.1-0.25-0.13-0.52-0.72-0.1
0.38-0.16-0.140.33-0.24-0.670.170.880.17-0.230.910.68-0.080.18-0.280.830.460.94-0.71-0.12-0.24-0.29-0.49-0.59-0.14
0.97-0.27-0.350.85-0.98-0.641.00.470.17-0.380.510.69-0.331.0-0.350.52-0.180.37-0.66-0.39-0.4-0.01-0.24-0.770.24
-0.40.930.98-0.80.520.34-0.38-0.26-0.23-0.38-0.32-0.450.97-0.381.0-0.280.47-0.270.590.820.970.090.340.41-0.14
0.68-0.22-0.210.58-0.55-0.780.510.960.910.51-0.320.81-0.160.51-0.340.950.380.96-0.85-0.2-0.31-0.15-0.5-0.82-0.1
0.79-0.33-0.370.74-0.73-0.990.690.760.680.69-0.450.81-0.320.68-0.460.75-0.010.74-0.73-0.4-0.5-0.56-0.46-0.830.12
-0.30.951.0-0.740.460.22-0.33-0.1-0.08-0.330.97-0.16-0.32-0.310.96-0.130.49-0.110.480.850.950.040.310.3-0.16
0.97-0.26-0.340.84-0.97-0.641.00.470.181.0-0.380.510.68-0.31-0.340.52-0.170.37-0.65-0.37-0.38-0.01-0.22-0.770.23
-0.380.920.97-0.780.50.36-0.35-0.27-0.28-0.351.0-0.34-0.460.96-0.34-0.290.44-0.290.60.820.970.120.350.41-0.13
0.68-0.19-0.190.56-0.54-0.730.521.00.830.52-0.280.950.75-0.130.52-0.290.370.97-0.84-0.13-0.27-0.08-0.53-0.73-0.08
-0.070.330.48-0.30.25-0.04-0.180.40.46-0.180.470.38-0.010.49-0.170.440.370.42-0.060.50.540.230.1-0.05-0.21
0.56-0.18-0.170.47-0.41-0.720.370.990.940.37-0.270.960.74-0.110.37-0.290.970.42-0.81-0.12-0.26-0.17-0.54-0.68-0.1
-0.770.450.53-0.810.740.65-0.66-0.82-0.71-0.660.59-0.85-0.730.48-0.650.6-0.84-0.06-0.810.520.61-0.010.680.82-0.04
-0.360.680.86-0.710.550.32-0.39-0.1-0.12-0.390.82-0.2-0.40.85-0.370.82-0.130.5-0.120.520.90.240.470.39-0.27
-0.40.850.96-0.790.550.41-0.4-0.25-0.24-0.40.97-0.31-0.50.95-0.380.97-0.270.54-0.260.610.90.230.480.42-0.15
-0.06-0.030.07-0.070.060.62-0.01-0.13-0.29-0.010.09-0.15-0.560.04-0.010.12-0.080.23-0.17-0.010.240.230.20.15-0.18
-0.320.190.36-0.40.340.43-0.24-0.52-0.49-0.240.34-0.5-0.460.31-0.220.35-0.530.1-0.540.680.470.480.20.440.22
-0.840.290.32-0.760.80.8-0.77-0.72-0.59-0.770.41-0.82-0.830.3-0.770.41-0.73-0.05-0.680.820.390.420.150.44-0.17
0.19-0.1-0.140.21-0.26-0.10.24-0.1-0.140.24-0.14-0.10.12-0.160.23-0.13-0.08-0.21-0.1-0.04-0.27-0.15-0.180.22-0.17
Click cells to compare fundamentals

Aethlon Medical Account Relationship Matchups

Aethlon Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets10.4M10.7M19.4M17.5M8.2M8.7M
Other Current Liab584.1K880.2K852.6K802.8K761.5K723.4K
Total Current Liabilities1.1M1.4M1.8M1.5M1.8M2.8M
Total Stockholder Equity9.4M9.4M17.1M15.1M5.8M6.1M
Net Debt(9.5M)(9.8M)(16.3M)(13.3M)(4.5M)(4.3M)
Retained Earnings(112.0M)(119.9M)(130.3M)(142.4M)(154.6M)(146.8M)
Cash9.6M9.9M17.1M14.5M5.4M3.0M
Non Current Assets Total346.6K317.2K1.3M2.4M2.3M2.4M
Cash And Short Term Investments9.6M9.9M17.1M14.5M5.4M3.0M
Common Stock Total Equity17.7K19.0K9.4K12.2K14.0K13.3K
Common Stock Shares Outstanding341.5K1.2M1.5M2.1M2.5M2.6M
Liabilities And Stockholders Equity10.4M10.7M19.4M17.5M8.2M8.7M
Other Stockholder Equity121.4M129.3M147.4M157.4M160.3M168.4M
Total Liab1.1M1.4M2.4M2.4M2.5M4.1M
Total Current Assets10.0M10.4M18.2M15.1M5.9M3.2M
Common Stock9.4K12.2K15.4K23.0K2.6K2.5K
Property Plant And Equipment Net276.9K201.3K1.1M2.3M1.9M2.0M
Accounts Payable285.0K337.7K500.0K432.9K777.9K566.0K
Property Plant And Equipment Gross276.9K201.3K1.1M2.3M2.9M3.0M
Intangible Assets57.5K57.0K2.2K1.7K1.1K1.0K
Short Long Term Debt Total141.1K42.5K729.4K1.2M940.3K949.8K
Other Current Assets229.6M341.1K1.9M557.6K506.0K480.7K
Accumulated Other Comprehensive Income(368.3K)(385.5K)0.0(6.1M)(6.9K)(7.3K)
Short Term Debt98.6K42.5K126.9K269.4K290.6K276.0K
Property Plant Equipment140.5K201.3K1.1M2.3M2.6M2.8M
Non Current Liabilities Total42.5K495.1K602.5K939.6K649.8K544.9K
Net Tangible Assets9.4M9.4M17.1M15.1M17.3M18.2M
Noncontrolling Interest In Consolidated Entity(101.2K)(126.0K)(132.1K)(136.9K)(123.2K)(117.1K)
Retained Earnings Total Equity(99.5M)(105.7M)(112.0M)(119.9M)(107.9M)(113.3M)
Capital Surpluse105.6M108.1M121.4M129.3M148.7M97.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.79)
Revenue Per Share
0.236
Quarterly Revenue Growth
42.782
Return On Assets
(0.50)
Return On Equity
(1.05)
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Trending Assets

RPID
Rapid Micro Biosystems
0.90  -0.1  -10 
OSA
ProSomnus, Common Stock
0.47  0.00  0.00 
DCTH
Delcath Systems
11.01  -0.17  -1.52 
HSCS
Heart Test Laboratories
3.83  0.41  11.99 
CVRX
CVRx Inc
12.11  0.39  3.33 
NUWE
Nuwellis
1.00  -0.01  -0.99 
BJDX
Bluejay Diagnostics
3.84  -0.06  -1.54 
VVOS
Vivos Therapeutics
4.98  0.32  6.87 
BBLG
Bone Biologics Corp
1.05  0.02  1.94 
RMED
RA Medical Systems
0.68  -0.02  -2.86 
OPGN
OpGen Inc
1.90  -0.15  -7.32 
NPCE
Neuropace
11.53  0.39  3.50 
SRDX
SurModics
39.75  -0.16  -0.4 
SINT
SINTX Technologies
3.52  -0.14  -3.83 
TLIS
Talis Biomedical Corp
0.00  0.00  0.00 
TIVC
Tivic Health Systems
0.21  0.01  5.00 
News Freq…Investor S…